Author： Millet R. Bertrand-Caumont K. Loison C. Goossens J.F. Houssin R. Hénichart J.P.
Publisher： Pharmaceutical Press
ISSN： 1460-8081
Source： Pharmacy and Pharmacology Communications, Vol.5, Iss.3, 1999-03, pp. : 169-171
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
By Robineau P. Lonchampt M. Kucharczyk N. Krause J.E. Regoli D. Fauchere J.-L. Prost J.-F. Canet E.
European Journal of Pharmacology, Vol. 294, Iss. 2, 1995-12 ,pp. :
Access to resources
Recommend
The dual nature of the tachykinin NK 1 receptor
Trends in Pharmacological Sciences, Vol. 18, Iss. 10, 1997-10 ,pp. :
SCH 206272: a potent, orally active tachykinin NK 1 , NK 2 , and NK 3 receptor antagonist
By Anthes J.C. Chapman R.W. Richard C. Eckel S. Corboz M. Hey J.A. Fernandez X. Greenfeder S. McLeod R. Sehring S. Rizzo C. Crawley Y. Shih N.-Y. Piwinski J. Reichard G. Ting P. Carruthers N. Cuss F.M. Billah M. Kreutner W. Egan R.W.
European Journal of Pharmacology, Vol. 450, Iss. 2, 2002-08 ,pp. :
By Muññoz Miguel Bernabeu-Wittel Joséé Coveññas Rafael
Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 7, 2011-07 ,pp. :